Literature DB >> 23299559

Economic analysis of a multi-site prevention program: assessment of program costs and characterizing site-level variability.

Phaedra S Corso1, Justin B Ingels, Steven M Kogan, E Michael Foster, Yi-Fu Chen, Gene H Brody.   

Abstract

Programmatic cost analyses of preventive interventions commonly have a number of methodological difficulties. To determine the mean total costs and properly characterize variability, one often has to deal with small sample sizes, skewed distributions, and especially missing data. Standard approaches for dealing with missing data such as multiple imputation may suffer from a small sample size, a lack of appropriate covariates, or too few details around the method used to handle the missing data. In this study, we estimate total programmatic costs for a prevention trial evaluating the Strong African American Families-Teen program. This intervention focuses on the prevention of substance abuse and risky sexual behavior. To account for missing data in the assessment of programmatic costs we compare multiple imputation to probabilistic sensitivity analysis. The latter approach uses collected cost data to create a distribution around each input parameter. We found that with the multiple imputation approach, the mean (95 % confidence interval) incremental difference was $2,149 ($397, $3,901). With the probabilistic sensitivity analysis approach, the incremental difference was $2,583 ($778, $4,346). Although the true cost of the program is unknown, probabilistic sensitivity analysis may be a more viable alternative for capturing variability in estimates of programmatic costs when dealing with missing data, particularly with small sample sizes and the lack of strong predictor variables. Further, the larger standard errors produced by the probabilistic sensitivity analysis method may signal its ability to capture more of the variability in the data, thus better informing policymakers on the potentially true cost of the intervention.

Entities:  

Mesh:

Year:  2013        PMID: 23299559      PMCID: PMC3638081          DOI: 10.1007/s11121-012-0316-z

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  42 in total

1.  Universal family-focused interventions in alcohol-use disorder prevention: cost-effectiveness and cost-benefit analyses of two interventions.

Authors:  Richard L Spoth; Max Guyll; Susan X Day
Journal:  J Stud Alcohol       Date:  2002-03

Review 2.  The distribution of health care costs and their statistical analysis for economic evaluation.

Authors:  A Briggs; A Gray
Journal:  J Health Serv Res Policy       Date:  1998-10

3.  Cost-benefit and cost-effectiveness analysis of drug abuse treatment services.

Authors:  W S Cartwright
Journal:  Eval Rev       Date:  1998-10

4.  Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Authors:  Karl Claxton; Mark Sculpher; Chris McCabe; Andrew Briggs; Ron Akehurst; Martin Buxton; John Brazier; Tony O'Hagan
Journal:  Health Econ       Date:  2005-04       Impact factor: 3.046

5.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

Review 6.  Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches.

Authors:  Sherri L Pals; David M Murray; Catherine M Alfano; William R Shadish; Peter J Hannan; William L Baker
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

7.  Economic analysis of methamphetamine prevention effects and employer costs.

Authors:  Max Guyll; Richard Spoth; D Max Crowley
Journal:  J Stud Alcohol Drugs       Date:  2011-07       Impact factor: 2.582

8.  Community prevention of alcohol problems.

Authors:  H D Holder
Journal:  Addict Behav       Date:  2000 Nov-Dec       Impact factor: 3.913

9.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.

Authors:  Jonathan A C Sterne; Ian R White; John B Carlin; Michael Spratt; Patrick Royston; Michael G Kenward; Angela M Wood; James R Carpenter
Journal:  BMJ       Date:  2009-06-29

10.  Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.

Authors:  Ramin Mojtabai; Joshua Graff Zivin
Journal:  Health Serv Res       Date:  2003-02       Impact factor: 3.402

View more
  2 in total

1.  Cost-effectiveness of the strong African American families-teen program: 1-year follow-up.

Authors:  Justin B Ingels; Phaedra S Corso; Steve M Kogan; Gene H Brody
Journal:  Drug Alcohol Depend       Date:  2013-08-15       Impact factor: 4.492

Review 2.  Understanding cost data collection tools to improve economic evaluations of health interventions.

Authors:  John M Chapel; Guijing Wang
Journal:  Stroke Vasc Neurol       Date:  2019-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.